1. Okazaki K, Uchida K, Matsushita M, Takaoka M. Autoimmune pancreatitis. Intern Med. 2005; 44:1215–1223.
Article
2. Kamisawa T, Egawa N, Nakajima H, et al. Comparison of radiological and histological findings in autoimmune pancreatitis. Hepatogastroenterology. 2006; 53:953–956.
3. Oh HC, Kim MH, Lee KT, et al. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2010; 25:1831–1837.
Article
4. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732–738.
Article
5. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 14:3948–3955.
Article
6. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of carbohydrate antigen 19–9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004; 19:182–186.
Article
7. Yoon H, Kim MH, Won SH, et al. A comparative study on serum immunoglobulin and tumor marker levels in the patients with autoimmune pancreatitis and pancreatobiliary malignancies. Korean J Gastroenterol. 2013; 61:327–332.
Article
8. Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associ-ated cholangitis from cholangiocarcinoma. Hepatology. 2011; 54:940–948.
Article
9. Ohara H, Nakazawa T, Kawa S, et al. Establishment of a serum igg4 cut-off value for the differential diagnosis of igg4-related sclerosing cholangitis-A Japanese cohort. J Gastroenterol Hepatol. 2013. [Epub ahead of print].
10. Kanno A, Nishimori I, Masamune A, et al. Research Committee on Intractable Diseases of Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas. 2012; 41:835–839.
Article